353 related articles for article (PubMed ID: 18829784)
1. An intervention to decrease narcotic-related adverse drug events in children's hospitals.
Sharek PJ; McClead RE; Taketomo C; Luria JW; Takata GS; Walti B; Tanski M; Nelson C; Logsdon TR; Thurm C; Federico F
Pediatrics; 2008 Oct; 122(4):e861-6. PubMed ID: 18829784
[TBL] [Abstract][Full Text] [Related]
2. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
[TBL] [Abstract][Full Text] [Related]
3. Relevance of the Agency for Healthcare Research and Quality Patient Safety Indicators for children's hospitals.
Sedman A; Harris JM; Schulz K; Schwalenstocker E; Remus D; Scanlon M; Bahl V
Pediatrics; 2005 Jan; 115(1):135-45. PubMed ID: 15579669
[TBL] [Abstract][Full Text] [Related]
4. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
[TBL] [Abstract][Full Text] [Related]
5. Assessing controlled substance prescribing errors in a pediatric teaching hospital: an analysis of the safety of analgesic prescription practice in the transition from the hospital to home.
Lee BH; Lehmann CU; Jackson EV; Kost-Byerly S; Rothman S; Kozlowski L; Miller MR; Pronovost PJ; Yaster M
J Pain; 2009 Feb; 10(2):160-6. PubMed ID: 19010736
[TBL] [Abstract][Full Text] [Related]
6. Medication safety program reduces adverse drug events in a community hospital.
Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
[TBL] [Abstract][Full Text] [Related]
7. Analysis of adverse events in pediatric surgery using criteria validated from the adult population: justifying the need for pediatric-focused outcome measures.
Rice-Townsend S; Hall M; Jenkins KJ; Roberson DW; Rangel SJ
J Pediatr Surg; 2010 Jun; 45(6):1126-36. PubMed ID: 20620307
[TBL] [Abstract][Full Text] [Related]
8. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
Benjamin DM; Pendrak RF
J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reactions among children over a 10-year period.
Le J; Nguyen T; Law AV; Hodding J
Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
[TBL] [Abstract][Full Text] [Related]
10. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.
Tham E; Calmes HM; Poppy A; Eliades AB; Schlafly SM; Namtu KC; Smith DM; Vitaska MC; McConnell C; Potts AL; Jastrzembski J; Logsdon TR; Hall M; Takata GS
Pediatrics; 2011 Aug; 128(2):e438-45. PubMed ID: 21727100
[TBL] [Abstract][Full Text] [Related]
11. Effective interventions and implementation strategies to reduce adverse drug events in the Veterans Affairs (VA) system.
Mills PD; Neily J; Kinney LM; Bagian J; Weeks WB
Qual Saf Health Care; 2008 Feb; 17(1):37-46. PubMed ID: 18245218
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the agency for healthcare research and quality pediatric quality indicators.
Scanlon MC; Harris JM; Levy F; Sedman A
Pediatrics; 2008 Jun; 121(6):e1723-31. PubMed ID: 18474532
[TBL] [Abstract][Full Text] [Related]
13. A multidisciplinary approach to adverse drug events in pediatric trauma patients in an adult trauma center.
Kalina M; Tinkoff G; Gleason W; Veneri P; Fulda G
Pediatr Emerg Care; 2009 Jul; 25(7):444-6. PubMed ID: 19564808
[TBL] [Abstract][Full Text] [Related]
14. Risk reduction for adverse drug events through sequential implementation of patient safety initiatives in a children's hospital.
Leonard MS; Cimino M; Shaha S; McDougal S; Pilliod J; Brodsky L
Pediatrics; 2006 Oct; 118(4):e1124-9. PubMed ID: 17015504
[TBL] [Abstract][Full Text] [Related]
15. A systems approach to preventing adverse drug events.
Anderson JG
Stud Health Technol Inform; 2003; 92():95-102. PubMed ID: 15455844
[TBL] [Abstract][Full Text] [Related]
16. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.
Stelfox HT; Ahmed SB; Fiskio J; Bates DW
Clin Pharmacol Ther; 2004 Jan; 75(1):110-22. PubMed ID: 14749697
[TBL] [Abstract][Full Text] [Related]
17. The relationship between computerized physician order entry and pediatric adverse drug events: a nested matched case-control study.
Yu F; Salas M; Kim YI; Menachemi N
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):751-5. PubMed ID: 19479715
[TBL] [Abstract][Full Text] [Related]
18. Introduction--databases and the assessment of complications associated with the treatment of patients with congenital cardiac disease.
Jacobs JP
Cardiol Young; 2008 Dec; 18 Suppl 2():1-37. PubMed ID: 19063774
[TBL] [Abstract][Full Text] [Related]
19. Improving self-reporting of adverse drug events in a West Virginia hospital.
Schade CP; Hannah K; Ruddick P; Starling C; Brehm J
Am J Med Qual; 2006; 21(5):335-41. PubMed ID: 16973950
[TBL] [Abstract][Full Text] [Related]
20. [Clinical safety paediatric patients].
Requena J; Miralles JJ; Mollar J; Aranaz JM
Rev Calid Asist; 2011; 26(6):353-8. PubMed ID: 22033382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
